SFX by Ex Libris Inc.

Title:	Retinoids selective for retinoid X receptor response pathways
Source:	Science [0036-8075] Lehmann, J M yr:1992

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dmitrovsky, E. "Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells." Journal of the National Cancer Institute 91.4 (1999): 373-379.
description	2.	Dawson, M I. "The retinoid X receptors and their ligands." Biochimica and biophysica acta. Molecular and cell biology of lipids 1821.1 (2012): 21-56.
description	3.	Yotsumoto, T. "A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin level in KK-Ay mice under normal dietary conditions." Metabolism, clinical and experimental 54.5 (2005): 573-8.
description	4.	Wang, S. "Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors." Clinical cancer research 15.21 (2009): 6484-6489.
description	5.	Ebisawa, M. "Retinoid X receptor-antagonistic diazepinylbenzoic acids." Chemical & pharmaceutical bulletin 47.12: 1778-1786.
description	6.	Wang, Y-N N. "Nuclear trafficking of the epidermal growth factor receptor family membrane proteins." Oncogene 29.28 (2010): 3997-4006.
description	7.	Soler, M. "HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells." International journal of cancer 125.11 (2009): 2565-2575.
description	8.	Meyn, R. "Receptor signaling as a regulatory mechanism of DNA repair." Radiotherapy and Oncology 92.3 (2009): 316-322.
description	9.	Biesalski, H K K. "Comparative assessment of the toxicology of vitamin A and retinoids in man." Toxicology 57.2 (1989): 117-61.
description	10.	Peltola, K. "Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor." Neoplasia 11.7 (2009): 629-636.
description	11.	Pirog, Yao-Tseng F. "Clinical, Pathologic, and Molecular Features of Early-onset Colorectal Carcinoma." The American journal of surgical pathology 33.4 (2008): 572-82.
description	12.	Dawson, M I I. "Synthetic retinoids and their nuclear receptors." Current medicinal chemistry. Anti-cancer agents 4.3 (2004): 199-230.
description	13.	Gronemeyer, H. "Principles for modulation of the nuclear receptor superfamily." Nature reviews. Drug discovery 3.11 (2004): 950-64.
description	14.	Sibilia, M. "The epidermal growth factor receptor: from development to tumorigenesis." Differentiation 75.9 (2007): 770-787.
description	15.	Gazdar, A F. "Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors." Oncogene 28.1 (2009): 24-31.
description	16.	Überall, I. "The status and role of ErbB receptors in human cancer." Experimental and Molecular Pathology 84.2 (2008): 79-89.
description	17.	Dong, Q. "Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy." Anti-cancer drugs 25.3 (2013): 346-352.
description	18.	Pines, Wolfgang r. "Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy." FEBS letters 584.12 (2010): 2699-2706.
description	19.	Rodemann, H. "Nuclear EGFR as Novel Therapeutic Target Insights into Nuclear Translocation and Function." Strahlentherapie und Onkologie 186.1 (2010): 1-6.
description	20.	Dittmann, Mayer C. "Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport." Radiotherapy and Oncology 92.3 (2009): 379-382.